CVE-2026-47419praisonai-platform: Agent endpoints accept any agent_id without workspace ownership check, cross-workspace read/update/delete IDOR
Updated under an hour ago ()
Does this affect you?
It affects MervinPraison praisonai-platform. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
PraisonAI Platform is the platform layer for the PraisonAI multi-agent teams system. Versions prior to 0.1.4 have an* Insecure Direct Object Reference. The agent CRUD endpoints (`GET / PATCH / DELETE /workspaces/{workspace_id}/agents/{agent_id}`) gate access on `require_workspace_member(workspace_id)` only, then resolve `agent_id` through `AgentService.get(agent_id)` which is a primary-key lookup with no workspace constraint. A user who is a member of any workspace `W1` can read, modify, or delete agents that belong to a different workspace `W2` by guessing or harvesting an agent UUID and calling `…/workspaces/W1/agents/<W2-agent-id>`. PraisonAI Platform version 0.1.4 patches the issue.
- CVSS
- 8.3 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L
- Weakness (CWE)
- CWE-639
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- GitHub_M
- NVD analysis
- Deferred
- Record last updated
- Jul 22, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
MervinPraison praisonai-platform mervinpraison:praisonai_platform (from the name) | before 0.1.4 | CNA record |
References
- https://github.com/MervinPraison/PraisonAI/security/advisories/GHSA-7p8g-6c6g-h9w7x-refsource-confirm
- https://github.com/MervinPraison/PraisonAI/commit/ef79b7a0561796ad9807f0f09538c25cc78d3619x-refsource-misc
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.